These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog. Ohuchi K, Funato M, Kato Z, Seki J, Kawase C, Tamai Y, Ono Y, Nagahara Y, Noda Y, Kameyama T, Ando S, Tsuruma K, Shimazawa M, Hara H, Kaneko H. Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872 [Abstract] [Full Text] [Related]
19. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Riessland M, Ackermann B, Förster A, Jakubik M, Hauke J, Garbes L, Fritzsche I, Mende Y, Blumcke I, Hahnen E, Wirth B. Hum Mol Genet; 2010 Apr 15; 19(8):1492-506. PubMed ID: 20097677 [Abstract] [Full Text] [Related]
20. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration. Arnold WD, Duque S, Iyer CC, Zaworski P, McGovern VL, Taylor SJ, von Herrmann KM, Kobayashi DT, Chen KS, Kolb SJ, Paushkin SV, Burghes AH. PLoS One; 2016 Apr 15; 11(12):e0167077. PubMed ID: 27907033 [Abstract] [Full Text] [Related] Page: [Next] [New Search]